Correlation Between Keros Therapeutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on Keros Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Larimar Therapeutics.
Diversification Opportunities for Keros Therapeutics and Larimar Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Keros and Larimar is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Larimar Therapeutics
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.52 times more return on investment than Larimar Therapeutics. However, Keros Therapeutics is 1.94 times less risky than Larimar Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 5,964 in Keros Therapeutics on August 31, 2024 and sell it today you would lose (109.00) from holding Keros Therapeutics or give up 1.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Keros Therapeutics vs. Larimar Therapeutics
Performance |
| Timeline |
| Keros Therapeutics |
| Larimar Therapeutics |
Keros Therapeutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and Larimar Therapeutics
The main advantage of trading using opposite Keros Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |